Alpha Articles
Strong in vivo data for Algeta's radioactive MAb
27 March 2006
Viragen reveals financing strategy
20 March 2006
Good psoriasis data for Centocor's Remicade
13 March 2006
Medarex' full-year 2005 loss narrows 28%
13 March 2006
Strong Ph II data for Algeta's Alpharadin
13 March 2006
Viragen's Multiferon approved in Sweden
27 February 2006
Pfizer's Lyrica gets CHMP nod as GAD drug
6 February 2006
CMHP issues positive opinion to S-P/Centocor's Remicade edging; closer to approval in the EU
6 February 2006
Japan stock market 3 weeks to Jan 2, 2006
9 January 2006
Teva, Three RIvers and Par get final OK for generic ribavarin
12 December 2005
Borean's TNF anatagonist yields positive preclinical data
12 December 2005
Viragen's Multiferon promising in H5N1 trial
5 December 2005
Helix' Ph II topical interferon trial approved by Sweden
19 September 2005
Amicus reports good Ph I results with Amigal
19 September 2005
Michael J Fox Foundation award for Alnylam
22 August 2005
Alnylam and Nastech sign RNAi accord
1 August 2005
BioXell initiates Ph IIb trial of BXL628 in BPH
18 July 2005
BI's Flomax shows good AE profile
18 July 2005
Amarillo to start Turkish trial of oral INF
18 July 2005
Japan stock market week to June 27
4 July 2005
Boeh Ingelheim debuts new tamsulosin pill
27 June 2005
Elan: promising mice data in new PD vaccine
27 June 2005
Watson starts enrollment in silodosin Ph III trial
27 June 2005
Astellas launches oral Harnal
20 June 2005
UK arthritis pharma care "still a lottery"
13 June 2005
FDA accepts Remicade for priority review
6 June 2005
Berna Biotech repositions Rhein Biotech GmbH
30 May 2005
Melanotan gives strong Ph I/II performace
30 May 2005
Teva to buy the remainder of Tianjin Hualida
30 May 2005
pSivida and EpiTan report on Melanotan study
23 May 2005
Serono and Genmab sign T cell drug deal
9 May 2005
Avanir signs $200M R&D deal with Novartis
9 May 2005
Viragen's Multiferon cleared in Philippines
25 April 2005
Avocado oil health benefits explored
25 April 2005
Japan stock market week to April 18
25 April 2005
One-time provisional charge blights Serono's 1st-qtr results, putting firm into a loss
22 April 2005
Domantis and Peptech find lead candidate
18 April 2005
Roche's MabThera to treat RA?
11 April 2005
SciClone's Zadaxin shows broad mechanism
11 April 2005
Maxygen gets milestone from Roche
11 April 2005
Memory unveils new drug candidate
11 April 2005
Australia's EpiTan plans UK AIM listing
4 April 2005
Amarillo to start trial of interferon alpha
21 March 2005
Renovis' Ph II trial of PHN drug misses endpoint
14 March 2005
Second Tysabri trial fatality confirmed
14 March 2005
Genzyme and gene transfer MS therapy
7 March 2005
EC approves Roche's Pegasys for hepatitis B
7 March 2005
UPDATE: Biogen and Elan pull MS drug Tysabri from the market on two cases of CNS disorder
7 March 2005
BioPartners signs 10-year license accord with The Medical House
28 February 2005
EpiTan buys regional OraDisc rights
14 February 2005
Viragen files Multiferon in Sweden for new use
14 February 2005
Serono sees slowing 4th-qtr profits
7 February 2005
CHMP recommends Roche's Pegasys as hep B therapy
31 January 2005
OctoPlus gains $23.8M in second financing
24 January 2005
Myzozyme MAA lifts Genzyme
10 January 2005
Flamel Tech initiates Medusa Phase I/II trial
10 January 2005
Xtrana and Alpha Innotech to merge
10 January 2005
FDA fast-track for J&J/S-P's Remicade
10 January 2005
Bayer divests plasma business for $590M
20 December 2004
Angel to produce Belerofon for Nautilus
13 December 2004
Sharp rise in 3rd-qtr loss for SciClone
8 November 2004
BioPartners files for biosimilar IFN-alpha
1 November 2004
EpiTan focuses on Melanotan, a potential blockbuster
1 November 2004
UPDATE: Serono tops forecasts as EPS rockets 54%
1 November 2004
Serono sees 3rd-qtr net income leaps 47%
1 November 2004
Viragen seeing increased demand for Multiferon in Mexico
25 October 2004
Promising new data for Viragen's Multiferon
11 October 2004
Elan/Biogen Idec's Antegren filed for Crohn's disease in EU
4 October 2004
Biolex opens new cGMP biopharma manufacturing facility
4 October 2004
Positive new data for UCB's CDP-870 in RA
27 September 2004
Showa Denko develops new tetralone synthesis catalyst
6 September 2004
Medimmune halts Vitaxin trials
6 September 2004
Blueberries may lower cholesterol; new study
30 August 2004
Biogen Idec/Elan's Antegren update
23 August 2004
Wyeth's temsirolimus on FDA fast-track
23 August 2004
Biogen Idec closes 2nd-qtr above expectations
9 August 2004
Omega-3s protect against prostate cancer
2 August 2004
Elan/Biogen's NDA for Antegren accepted
2 August 2004
Viragen to produce Multiferon at new Swedish facility
2 August 2004
Serono's 2nd-qtr net income jumps 26%
2 August 2004
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
